| Title: |
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study |
| Authors: |
Joerger, MarkusAff1, Aff2; Hundsberger, ThomasAff1, Aff3; Haefliger, SimonAff4; von Moos, RogerAff5; Hottinger, Andreas F.Aff6; Kaindl, ThomasAff7, IDs10637023013369_cor6; Engelhardt, MarcAff7; Marszewska, MichalinaAff7; Lane, HeidiAff7; Roth, PatrickAff8; Stathis, AnastasiosAff9 |
| Source: |
Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 41(2):267-275 |
| Database: |
Springer Nature Journals |